Literature DB >> 19701970

Different patterns of intestinal response to injury after arterial, venous or arteriovenous occlusion in rats.

Francisco Javier Guzmán-de la Garza1, Carlos Rodrigo Cámara-Lemarroy, Gabriela Alarcón-Galván, Paula Cordero-Pérez, Linda Elsa Muñoz-Espinosa, Nancy Esthela Fernández-Garza.   

Abstract

AIM: To investigate the differences in injury patterns caused by arterial, venous or arteriovenous mesenteric occlusion.
METHODS: Male Wistar rats were separated equally into four groups. Occlusion was performed by clamping the superior mesenteric artery (A), the mesenteric vein (V) or both (AV) for 30 min, followed by 60 min of reperfusion. A control group received sham surgery only. Intestinal sections were examined for histological damage and serum tumor necrosis factor-alpha (TNF-alpha), endothelin-1 (ET-1), P-selectin, antithrombin III (ATIII) and soluble intracellular adhesion molecule-1 (ICAM-1) concentrations were measured.
RESULTS: All groups showed significant mucosal injury compared to controls. Furthermore, mucosal injury was significantly more severe in the V and AV groups compared to the A group (3.6 +/- 0.55, 3.4 +/- 0.55 and 2 +/- 0.71, respectively P = 0.01). ICAM-1 was similarly elevated in all groups, with no significant differences between the groups. P-selectin levels were significantly elevated in the V and AV groups but not the A group (1.4 +/- 0.5 ng/mL, 2.52 +/- 0.9 ng/mL and 0.02 +/- 0.01 ng/mL, respectively, P = 0.01) and ET-1 was significantly elevated in the A and V groups but not the AV group (0.32 +/- 0.04 pg/mL, 0.36 +/- 0.05 pg/mL and 0.29 +/- 0.03 pg/mL, respectively, P = 0.01) compared to sham controls. ATIII levels were markedly depleted in the V and AV groups, but not in the A group (29.1 +/- 5.2 pg/mL, 31.4 +/- 21.8 pg/mL and 55.8 +/- 35.6 pg/mL, respectively, P = 0.01), compared to controls. Serum TNF-alpha was significantly increased in all groups compared to sham controls (1.32 +/- 0.87 ng/mL, 1.79 +/- 0.20 ng/mL and 4.4 +/- 0.69 ng/mL, for groups A, V and AV, respectively, P = 0.01), with higher values in the AV group.
CONCLUSION: Different patterns of response to ischemia/reperfusion are associated with venous, arterial or arteriovenous occlusion. Venous and arteriovenous occlusion was associated with the most severe alterations.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19701970      PMCID: PMC2731252          DOI: 10.3748/wjg.15.3901

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  38 in total

Review 1.  Diagnosis and management of intestinal ischaemic disorders.

Authors:  Jayaprakash Sreenarasimhaiah
Journal:  BMJ       Date:  2003-06-21

2.  Effects of inhibition of PAF, ICAM-1 and PECAM-1 on gut barrier failure caused by intestinal ischemia and reperfusion.

Authors:  Z Sun; X Wang; A Lasson; A Böjesson; M Annborn; R Andersson
Journal:  Scand J Gastroenterol       Date:  2001-01       Impact factor: 2.423

3.  Effective treatment of gut barrier dysfunction using an antioxidant, a PAF inhibitor, and monoclonal antibodies against the adhesion molecule PECAM-1.

Authors:  Zhengwu Sun; Knut Olanders; Ake Lasson; Marwan Dib; Martin Annborn; Klara Andersson; Xiangdong Wang; Roland Andersson
Journal:  J Surg Res       Date:  2002-06-15       Impact factor: 2.192

Review 4.  Pathophysiology of aortocoronary saphenous vein bypass graft disease.

Authors:  Seyed-Ahmad Hassantash; Behnood Bikdeli; Shadi Kalantarian; Maryam Sadeghian; Haleh Afshar
Journal:  Asian Cardiovasc Thorac Ann       Date:  2008-08

5.  Real-time energy metabolism of intestine during arterial versus venous occlusion in the rat.

Authors:  Masahiro Kimura; Makoto Kataoka; Yoshiyuki Kuwabara; Atsushi Sato; Masahiko Sugiura; Yoshitaka Fujii
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

6.  Calpain inhibitor I reduces intestinal ischemia-reperfusion injury in the rat.

Authors:  Stefania Marzocco; Rosanna Di Paola; Giuseppina Autore; Emanuela Mazzon; Aldo Pinto; Achille P Caputi; Cristoph Thiemermann; Salvatore Cuzzocrea
Journal:  Shock       Date:  2004-01       Impact factor: 3.454

7.  Ischemia-reperfusion injury following superior mesenteric artery occlusion and strangulation obstruction.

Authors:  Adem Akcakaya; Orhan Alimoglu; Mustafa Sahin; Semra Dogru Abbasoglu
Journal:  J Surg Res       Date:  2002-11       Impact factor: 2.192

8.  The effect of intestinal ischemia and reperfusion injury on ICAM-1 expression, endothelial barrier function, neutrophil tissue influx, and protease inhibitor levels in rats.

Authors:  Knut Olanders; Zhengwu Sun; Anna Börjesson; Marwan Dib; Ellen Andersson; Ake Lasson; Tomas Ohlsson; Roland Andersson
Journal:  Shock       Date:  2002-07       Impact factor: 3.454

9.  Heparin-binding EGF-like growth factor downregulates expression of adhesion molecules and infiltration of inflammatory cells after intestinal ischemia/reperfusion injury.

Authors:  Guliang Xia; Abigail E Martin; Gail E Besner
Journal:  J Pediatr Surg       Date:  2003-03       Impact factor: 2.545

10.  Effects of the anti-ICAM-1 monoclonal antibody, allopurinol, and methylene blue on intestinal reperfusion injury.

Authors:  Huseyin Ilhan; Ozkan Alatas; Baran Tokar; Omer çOlak; Ozgül Paşaoĝlu; Naim Koku
Journal:  J Pediatr Surg       Date:  2003-11       Impact factor: 2.545

View more
  8 in total

1.  Bacterial translocation and endotoxemia after pringle maneuver in cirrhotic rats.

Authors:  Yonghui Su; Haiyan Pan; Zhaowang Guo; Wenying Zhou; Baimeng Zhang
Journal:  Dig Dis Sci       Date:  2014-10-07       Impact factor: 3.199

2.  The effect of bevacizumab on colon anastomotic healing in rats.

Authors:  Efstathios T Pavlidis; Konstantinos D Ballas; Nikolaos G Symeonidis; Kyriakos Psarras; Georgios Koliakos; Kokona Kouzi-Koliakos; Konstantina Topouridou; Savas F Rafailidis; Theodoros E Pavlidis; Georgios N Marakis; Athanasios K Sakantamis
Journal:  Int J Colorectal Dis       Date:  2010-08-06       Impact factor: 2.571

3.  Increased endothelin-1 vasoconstriction in mesenteric resistance arteries after superior mesenteric ischaemia-reperfusion.

Authors:  S Martínez-Revelles; L Caracuel; A Márquez-Martín; Ap Dantas; E Oliver; P D'Ocon; E Vila
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

4.  Intestinal injury can be reduced by intra-arterial postischemic perfusion with hypertonic saline.

Authors:  Oleg Kornyushin; Michael Galagudza; Anna Kotslova; Gelfia Nutfullina; Nina Shved; Alexey Nevorotin; Valeriy Sedov; Timur Vlasov
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

5.  Hepatoprotective effect of commercial herbal extracts on carbon tetrachloride-induced liver damage in Wistar rats.

Authors:  Paula Cordero-Pérez; Liliana Torres-González; Marcelino Aguirre-Garza; Carlos Camara-Lemarroy; Francisco Guzmán-de la Garza; Gabriela Alarcón-Galván; Homero Zapata-Chavira; Ma de Jesús Sotelo-Gallegos; Cipactli Nadjedja Torres-Esquivel; Ethel Sánchez-Fresno; Daniel Cantú-Sepúlveda; Gerardo González-Saldivar; Judith Bernal-Ramirez; Linda E Muñoz-Espinosa
Journal:  Pharmacognosy Res       Date:  2013-07

6.  Prediction factors for ischemia of closed-loop small intestinal obstruction.

Authors:  Efstathios Theodoros Pavlidis; Theodoros Efstathios Pavlidis
Journal:  World J Gastrointest Surg       Date:  2022-09-27

7.  Novel biomarkers of arterial and venous ischemia in microvascular flaps.

Authors:  Gerard K Nguyen; Brian H Hwang; Yiqiang Zhang; John F W Monahan; Gabrielle B Davis; Yong Suk Lee; Neli P Ragina; Charles Wang; Zhao Y Zhou; Young Kwon Hong; Ryan M Spivak; Alex K Wong
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

8.  Temporal relationship of serum markers and tissue damage during acute intestinal ischemia/reperfusion.

Authors:  Francisco Javier Guzmán-de la Garza; Juan Manuel Ibarra-Hernández; Paula Cordero-Pérez; Pablo Villegas-Quintero; Claudia Ivette Villarreal-Ovalle; Liliana Torres-González; Norma Edith Oliva-Sosa; Gabriela Alarcón-Galván; Nancy Esthela Fernández-Garza; Linda Elsa Muñoz-Espinosa; Carlos Rodrigo Cámara-Lemarroy; José Gerardo Carrillo-Arriaga
Journal:  Clinics (Sao Paulo)       Date:  2013-07       Impact factor: 2.365

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.